Orthofix preliminary 2017 sales gross $434M: 5 things to know

Mackenzie Garrity -   Print  |

Orthofix released its preliminary 2017 fourth quarter and fiscal year 2017 year-end net sales results.

Here are five things to know:


1. The company expects to see roughly $117 million in fourth quarter 2017 sales, a 7.7 percent increase compared to fourth quarter 2016 sales.


2. Year-over-year Orthofix anticipates $434 million in sales, a 5.9 percent increase compared to 2016 year-end sales.


3. Orthofix reported $81 million in cash and cash equivalents Dec. 31, 2017. In 2016, the company reported $40 million.


4. In 2018, Orthofix predicts to see between $450 and $455 million in net sales.


5. Brad Mason, president and CEO of Orthofix, said the growth is organic and in 2018 the company plans to continue investing in research and development.


More articles on devices and implants:
Globus Medical to report $635.4M in 2017 revenue: 5 insights
Global spine surgery products market to grow at 5.8% CAGR through 2025 — 5 observations
Stryker sees $12.4B net sales in 2017; neurotechnology, spine sales reach $2.2B — 9 highlights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers